Cork, Ireland diagnostics company founded in 2011 that develops biomarker tests for preeclampsia and other pregnancy-related complications.
Based in Cork, Ireland, and founded in 2011, Metabolomic Diagnostics Ltd. provides a mass spectrometry-based diagnostic platform with biomarker tests for predicting and preventing complicated diseases. Its offerings include preeclampsia screening and maternal health diagnostics for medical institutions and maternal health practitioners. In September 2024 Trinity Biotech, a portfolio company of DeltaPoint Capital Partners, acquired the company for approximately USD 1.3 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in